Merck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting Pill Barron'sFDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment WSJMerck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment Fierce PharmaMerck gets US FDA nod for first-in-its-class oral cholesterol drug ETPharma.comThe F.D.A. Approves a New Pill to Slash Cholesterol Levels The New York Times
Key Highlights
Merck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting Pill Barron'sFDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment WSJMerck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment Fierce PharmaMerck gets US FDA nod for first-in-its-class oral cholesterol drug ETPharma.comThe F.D.A. Approves a New Pill to Slash Cholesterol Levels The New York Times
Frequently Asked Questions
What is this about?
Merck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting Pill Barron'sFDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment WSJMerck scores at FDA as Lipfendra becomes world's first oral PCSK9…